BCL2L14 anticorps (AA 298-312)
Aperçu rapide pour BCL2L14 anticorps (AA 298-312) (ABIN636238)
Antigène
Voir toutes BCL2L14 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 298-312
-
Purification
- Affinity chromatography purified
-
Immunogène
- Bcl-G antibody was raised in rabbit using AA 298-312 [TKYLKENFSPWIQQH] of the human BCL-G Long form protein as the immunogen.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- BCL2L14 (BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14))
-
Sujet
- Bcl-G is a novel pro-apoptotic member of the Bcl-2 family. The human BCL-G gene encodes two proteins through alternative mRNA splicing, Bcl-G(L) (long) and Bcl-G(S) (short) consisting of 327 and 252 amino acids in length, respectively. Bcl-G(L) mRNA is expressed widely in adult human tissues, whereas Bcl-G(S) mRNA was found only in testis. Overexpression of Bcl-G(L) or Bcl-G(S) in cells induced apoptosis although Bcl-G(S) was far more potent than Bcl-G(L).
Antigène
-